ODYSSEY Outcomes: High-risk Patients Benefit More From PCSK9s ODYSSEY Outcomes: High-risk Patients Benefit More From PCSK9s

Two ODYSSEY Outcomes subgroup analyses shed light on the benefits of PCSK9 inhibition in patients with polyvascular disease and previous CABG.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news